Literature DB >> 33554740

When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes.

Marilyn M Schapira1,2, Keri L Rodriguez3,4, Sumedha Chhatre1,5, Liana Fraenkel6,7, Lori A Bastian6,7, Jeffrey D Kravetz6,7, Onur Asan8, Scott Akers9, Anil Vachani10,11, Jason M Prigge1, Jessica Meline1, Jennifer V Ibarra6, Barbara Corn6, Dana Kaminstein1,12.   

Abstract

BACKGROUND: A shared decision-making (SDM) process for lung cancer screening (LCS) includes a discussion between clinicians and patients about benefits and potential harms. Expert-driven taxonomies consider mortality reduction a benefit and consider false-positives, incidental findings, overdiagnosis, overtreatment, radiation exposure, and direct and indirect costs of LCS as potential harms.
OBJECTIVE: To explore whether patients conceptualize the attributes of LCS differently from expert-driven taxonomies.
DESIGN: Cross-sectional study with semistructured interviews and a card-sort activity. PARTICIPANTS: Twenty-three Veterans receiving primary care at a Veterans Affairs Medical Center, 55 to 73 y of age with 30 or more pack-years of smoking. Sixty-one percent were non-Hispanic African American or Black, 35% were non-Hispanic White, 4% were Hispanic, and 9% were female. APPROACH: Semistructured interviews with thematic coding. MAIN MEASURES: The proportion of participants categorizing each attribute as a benefit or harm and emergent themes that informed this categorization. KEY
RESULTS: In addition to categorizing reduced lung cancer deaths as a benefit (22/23), most also categorized the following as benefits: routine annual screening (8/9), significant incidental findings (20/23), follow-up in a nodule clinic (20/23), and invasive procedures (16/23). Four attributes were classified by most participants as a harm: false-positive (13/22), overdiagnosis (13/23), overtreatment (6/9), and radiation exposure (20/22). Themes regarding the evaluation of LCS outcomes were 1) the value of knowledge about body and health, 2) anticipated positive and negative emotions, 3) lack of clarity in terminology, 4) underlying beliefs about cancer, and 5) risk assessment and tolerance for uncertainty.
CONCLUSIONS: Anticipating discordance between patient- and expert-driven taxonomies of the benefits and harms of LCS can inform the development and interpretation of value elicitation and SDM discussions.

Entities:  

Keywords:  card-sort activity; lung cancer screening; patient values; shared decision making; value elicitation

Year:  2021        PMID: 33554740     DOI: 10.1177/0272989X20987221

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  2 in total

1.  A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis.

Authors:  Marilyn M Schapira; Sumedha Chhatre; Jason M Prigge; Jessica Meline; Dana Kaminstein; Keri L Rodriguez; Liana Fraenkel; Jeffrey D Kravetz; Jeff Whittle; Lori A Bastian; Anil Vachani; Scott Akers; Susan Schrand; Jennifer V Ibarra; Onur Asan
Journal:  JMIR Form Res       Date:  2022-04-08

2.  Using Mixed Methods With Multiple Stakeholders to Inform Development of a Breast Cancer Screening Decision Aid for Women With Limited Health Literacy.

Authors:  Christine M Gunn; Ariel Maschke; Michael K Paasche-Orlow; Ashley J Housten; Nancy R Kressin; Mara A Schonberg; Tracy A Battaglia
Journal:  MDM Policy Pract       Date:  2021-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.